Lancet Oncology Publishes List of Drugs to Avoid for Patients on Tyrosine Kinase Inhibitors
Lancet Oncology, a comprehensive overview of known or suspected drug-drug interactions between tyrosine-kinase inhibitors (Gleevec, Sutent, Stivarga) prescribed for GIST.